Supraspinal and spinal effects of [Phe1Ψ(CH2-NH)Gly2]-nociceptin(1–13)-NH2 on nociception in the rat
- 10 December 1999
- journal article
- Published by Elsevier in Life Sciences
- Vol. 66 (3) , 257-264
- https://doi.org/10.1016/s0024-3205(99)00588-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- ORL1, a novel member of the opioid receptor familyPublished by Wiley ,2001
- Evidence that [Phe1ψ(CH2‐NH)Gly2]nociceptin‐(1‐13)‐NH2, a peripheral ORL‐1 receptor antagonist, acts as an agonist in the rat spinal cordBritish Journal of Pharmacology, 1998
- Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assayBritish Journal of Pharmacology, 1998
- [Phe1Ψ(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cordNeuroscience Letters, 1998
- Bidirectional modulatory effect of orphanin FQ on morphine‐induced analgesia: antagonism in brain and potentiation in spinal cord of the ratBritish Journal of Pharmacology, 1997
- Biochemical Evidence for Orphanin FQ/Nociceptin Receptor Heterogeneity in Mouse BrainBiochemical and Biophysical Research Communications, 1997
- Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled ReceptorScience, 1995
- Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptorNature, 1995
- cDNA Cloning of an orphan opiate receptor gene family member and its splice variantFEBS Letters, 1994
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983